Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum Cancer
Abroad (travel likely)RecruitingPHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Colorectal Cancer · BRAF V600E Mutation Positive
Locations
- Chu - Hôpital Européen Georges Pompidou, Paris, France